Health care
Recent articles
Perspectives from the field: Opinions in autism research
This collection of Spectrum articles from the past 12 months highlights expert perspectives on autism’s heritability and its link to biological sex, the value of transdiagnostic frameworks, and the field’s future, among other topics.
Perspectives from the field: Opinions in autism research
This collection of Spectrum articles from the past 12 months highlights expert perspectives on autism’s heritability and its link to biological sex, the value of transdiagnostic frameworks, and the field’s future, among other topics.
To accelerate the study of neurodevelopment, we need a transdiagnostic framework
Our tendency to focus on one condition at a time likely silos expertise and services—and obscures critical connections across diagnostic categories.
To accelerate the study of neurodevelopment, we need a transdiagnostic framework
Our tendency to focus on one condition at a time likely silos expertise and services—and obscures critical connections across diagnostic categories.
Building an autism research registry: Q&A with Tony Charman
A purpose-built database of participants who have shared genomic and behavioral data could give clinical trials a boost, Charman says.
Building an autism research registry: Q&A with Tony Charman
A purpose-built database of participants who have shared genomic and behavioral data could give clinical trials a boost, Charman says.
Leveraging the power of community to strengthen clinical trials for rare genetic syndromes
Families can become not only participants but champions of these research efforts.
Leveraging the power of community to strengthen clinical trials for rare genetic syndromes
Families can become not only participants but champions of these research efforts.
Pinning down ‘profound autism’ for reliable research: Q&A with Matthew Siegel
A clear and actionable definition for the term could enhance research and improve care, Matthew Siegel says.
Pinning down ‘profound autism’ for reliable research: Q&A with Matthew Siegel
A clear and actionable definition for the term could enhance research and improve care, Matthew Siegel says.
The perils of parachute research
Scientists who study autism in lower-income countries are working to end practices that exploit or ignore collaborators and communities on the ground.
The perils of parachute research
Scientists who study autism in lower-income countries are working to end practices that exploit or ignore collaborators and communities on the ground.
Year in Review: Spectrum’s best in 2023
Here are five must-reads from our coverage of autism research over the past 12 months.
Year in Review: Spectrum’s best in 2023
Here are five must-reads from our coverage of autism research over the past 12 months.
Head of company that accredits autism service providers resigns after article retraction
The resignation follows reporting by Spectrum and Retraction Watch in October about nonexistent references in the retracted article.
Head of company that accredits autism service providers resigns after article retraction
The resignation follows reporting by Spectrum and Retraction Watch in October about nonexistent references in the retracted article.
Article defending private-equity involvement in autism services retracted
Nearly two-thirds of the article’s references appear to not exist.
Article defending private-equity involvement in autism services retracted
Nearly two-thirds of the article’s references appear to not exist.
Scammers threaten quality of research survey data
Jammed online surveys and invaded video calls are forcing researchers to rethink their outreach methods.
Scammers threaten quality of research survey data
Jammed online surveys and invaded video calls are forcing researchers to rethink their outreach methods.
Explore more from The Transmitter
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Exclusive: The 23 studies the FDA based its expanded leucovorin label on
The studies include 46 people, mostly toddlers, who have cerebral folate deficiency due to variants in a folate transporter.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Autism researchers ‘pleasantly surprised’ by list of NIH data project grantees, despite initial concerns
An atypical funding mechanism, truncated application timeline and opaque review process had generated concern over the quality of projects that would be selected for the Autism Data Science Initiative.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.
Exclusive: Who is Richard Frye, the neurologist who researches and advocates for leucovorin as an autism treatment?
Frye has led two placebo-controlled trials of the folate supplement in autistic people; the first was suspended by regulators, and the other has yet to be published.